Amantadine use in the French prospective NS-Park cohort.

Margherita FabbriVanessa RousseauJean-Christophe CorvolAgnès SommetFlorence TubachYann De RyckeNathalie BertilleYajiththa SelvarasaStephanie CarvalhoVéronique ChaigneauChristine Brefel-CourbonFabienne Ory-MagneSamuel TessierMelissa TirMatthieu BereauWassilios G MeissnerClaire ThiriezAna MarquesPhilippe RemyVincent SchneiderElena MoroLuc DefebvreJean Luc HouetoStephane PrangeAlexandre EusebioChristian GenySolène FrismandPhilippe DamierCaroline Giordana ReutherGiovanni CastelnovoIsabelle BenatruAnne Doe De MaindrevilleSophie DrapierDavid MaltêteOuhaid Lagha-BoukbizaOlivier Rascolnull null

Published in: Journal of neural transmission (Vienna, Austria : 1996) (2024)

About 12% of PD patients within the French NS-Park cohort used amantadine, mostly those with younger age and more severe PD. Amantadine initiation was associated with a subsequent reduction in LIDs and MFs.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
dengue virus
prognostic factors
peritoneal dialysis
patient reported outcomes
zika virus